One-year atherothrombotic vascular events rates in outpatients with recent non-cardioembolic ischemic stroke: The EVEREST (Effective Vascular Event REduction after STroke) registry

Journal of Stroke and Cerebrovascular Diseases

Volumn 21, Issue 4, 2012, Pages 245-253

  Suzuki, Norihiro ^a   Sato, Motoki ^b   Houkin, Kiyohiro ^c   Terayama, Yasuo ^d   Uchiyama, Shinichiro ^e   Daida, Hiroyuki ^f   Shigematsu, Hiroshi ^g   Goto, Shinya ^h   Tanaka, Kortaro ⁱ   Origasa, Hideki ^j   Miyamoto, Susumu ^k   Minematsu, Kazuo ^l   Matsumoto, Masayasu ^m   Okada, Yasushi ⁿ  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sanofi aventis KK ^*  (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f JUNTENDO UNIVERSITY   (Japan)

^g INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^h TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ TOYAMA UNIVERSITY HOSPITAL   (Japan)

^j UNIVERSITY OF TOYAMA   (Japan)

^k KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^l NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^m HIROSHIMA UNIVERSITY   (Japan)

ⁿ NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

more..

Author keywords

Antiplatelet agents; cohort study; ischemic stroke; risk factors; secondary prevention

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; COHORT ANALYSIS; DIABETES MELLITUS; FATALITY; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; REGISTER; RISK ASSESSMENT; THROMBOSIS; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; INTRACRANIAL ARTERIOSCLEROSIS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; STROKE;

EID: 84860113848     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2012.01.010     Document Type: Article

References (30)

1. J.K. Liao Secondary prevention of stroke and transient ischemic attack: Is more platelet inhibition the answer? Circulation 115 2007 1615 1621 (Pubitemid 46648647)
2. R.L. Sacco, R. Adams, and G. Albers Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline Stroke 37 2006 577 617 (Pubitemid 43732031)
3. K.L. Furie, S.E. Kasner, and R.J. Adams Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 227 276
4. European Stroke Organisation (ESO) Executive Committee and ESO Writing Committee Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 Cerebrovas Dis 25 2008 457 507
5. G.W. Albers, P. Amarenco, and J.D. Easton Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 630S 669S (Pubitemid 351892974)
6. D.L. Bhatt, P.G. Steg, and E.M. Ohman International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis JAMA 295 2006 180 189 (Pubitemid 43076437)
7. P.G. Steg, D.L. Bhatt, and P.W. Wilson One-year cardiovascular event rates in outpatients with atherothrombosis JAMA 297 2007 1197 1206 (Pubitemid 46465728)
8. M.J. Alberts, D.L. Bhatt, and J.L. Mas Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry Eur Heart J 30 2009 2318 2326
9. D.L. Bhatt, K.A. Eagle, and E.M. Ohman Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis JAMA 304 2010 1350 1357
10. T. Yamazaki, S. Goto, and H. Shigematsu Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan: Results from domestic baseline data of the REduction of Atherothrombosis for Continued Health (REACH) Registry Circ J 71 2007 995 1003 (Pubitemid 46998011)
11. S. Uchiyama, S. Goto, and M. Matsumoto Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: Results from 1-year outcomes in the Japanese REACH registry J Neurol Sci 287 2009 45 51
12. K. Toyoda, Y. Okada, S. Kobayashi for the Japan Standard Stroke Registry Study group Early recurrence of ischemic stroke in Japanese patients: The Japan Standard Stroke Registry Study Cerebrovasc Dis 24 2007 289 295 (Pubitemid 47295599)
13. N. Suzuki, and M. Sato Registry and observational study in patients with stroke: EVEREST [in Japanese] Bunsi No Kekkannbyo 10 2011 27 31
14. J.C. van Swieten, P.J. Koudstaal, and M.C. Visser Interobserver agreement for the assessment of handicap in stroke patients Stroke 19 1988 604 607
15. H.P. Adams Jr., B.H. Bendixen, and L.J. Kappelle Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1993 35 41 (Pubitemid 23014379)
16. J. Hata, Y. Tanizaki, and Y. Kiyohara Ten year recurrence after first ever stroke in a Japanese community: The Hisayama study J Neurol Neurosurg Psychiatry 76 2005 368 372 (Pubitemid 40299127)
17. J. Lewsey, P.S. Jhund, and M. Gillies Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland BMC Med 8 2010 23 29
18. M. Girot, M.A. Mackowiak-Cordoliani, and D. Deplanque Secondary prevention after ischemic stroke. Evolution over time in practice J Neurol 252 2005 14 20 (Pubitemid 40179013)
19. PROGRESS Collaborative Group Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack Lancet 358 2001 1033 1041
20. P. Amarenco, and J. Labreuche Lipid management in the prevention of stroke: Review and updated meta-analysis of statins for stroke prevention Lancet Neurol 8 2009 453 463
21. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
22. H. Arima, C. Tzourio, and K. Butcher Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial Stroke 37 2006 1497 1502 (Pubitemid 44305732)
23. G.W. Petty, R.D. Brown Jr., and J.P. Whisnant Survival and recurrence after first cerebral infarction: A population-based study in Rochester, Minnesota, 1975 through 1989 Neurology 50 1998 208 216
24. J. Castillo, J. Alvarez-Sabín, and E. Martínez-Vila Inflammation markers and prediction of post-stroke vascular disease recurrence: The MITICO study J Neurol 256 2009 217 224
25. M.S. Elkind, W. Tai, and K. Coates Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke Cerebrovasc Dis 27 2009 42 50
26. P. Welsh, G.D. Lowe, and J. Chalmers Associations of proinflammatory cytokines with the risk of recurrent stroke Stroke 39 2008 2226 2230
27. A. Chandratheva, O.C. Geraghty, and P.M. Rothwell Poor performance of current prognostic scores for early risk of recurrence after minor stroke Stroke 42 2011 632 637
28. A. Chandratheva, O.C. Geraghty, and R. Luengo-Fernandez ABCD2 score predicts severity rather than risk of early recurrent events after transient ischemic attack Stroke 41 2010 851 856
29. C. Weimar, J. Benemann, and D. Michalski Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke: A prospective comparison of validated prognostic scores Stroke 41 2010 487 493
30. C. Weimar, H.C. Diener, and M.J. Alberts The Essen stroke risk score predicts recurrent cardiovascular events: A validation within the REduction of Atherothrombosis for Continued Health (REACH) registry Stroke 40 2009 350 354